Quality and cost assessment of Canadian Urological Association microscopic hematuria guidelines in clinical practice: Turning urine into gold

Keywords: quality improvement, patient safety, asymptomatic hematuria

Abstract

Introduction: Asymptomatic microscopic hematuria (AMH) is defined in the Canadian Urological Association (CUA) guideline as >2 red blood cells (RBCs) per high-powered field (HPF). Our objective was to evaluate guideline adherence for AMH at our center. Secondarily, we aimed to identify areas of the guideline that can be optimized.

Methods: We retrospectively reviewed 875 consecutive adults referred to two urologists for hematuria between June 2010 and June 2016. Patient characteristics, risk factors, and outcomes were added to an encrypted Research Electronic Data Capture (REDCap) database. Evaluation of microscopic hematuria reporting was performed by analyzing 681 urine samples reported as 1–5 RBC/HPF. Healthcare costs were obtained from Alberta Health Services (AHS), Data Integration and Management Repository (DIMR), and Alberta Society of Radiologists (ASR).

Results: Of the 875 patients referred with hematuria, 400 had AMH. Overall, 96.5% completed evaluation consistent with the CUA guideline. The incidence of pathology requiring surgical intervention was 21/400 (5%) with a 0.8% rate (3/400) of urothelial cell carcinoma (UCC) (non-invasive, low-grade). No malignancy was found in non-smokers with normal cytology, normal imaging and <50 RBC/HPF; 44% had AMH in the 1–5 RBCs/HPF range. Only 41% (279/681) of urine samples categorized as 1–5 RBCs/ HPF had guideline-defined microscopic hematuria. By changing local microscopic hematuria reporting to differentiate 1–2 and 3–5 RBCs/HPF, we estimate $745 000 in annual savings.

Conclusions: At our center, CUA AMH guideline adherence is high. We did not find malignancy in non-smokers with normal cytology, imaging and <50 RBC/HPF. We identified and changed regional microscopic hematuria reporting to fit the CUA definition, eliminating unnecessary investigations and healthcare costs.

References

Golin AL & Howard RS. Asymptomatic microscopic hematuria. J Urol. 1980; 124:389–91.

Mohr DN, Offord KP, Owen RA, et al. Asymptomatic microhematuria and urologic disease: a population-based study. JAMA 1986; 256:224–9.

Sultana SR, Goodman CM, Byrne DJ, et al. Microscopic hematuria: urological investigation using a standard protocol. Br J Urol. 1996; 78:691–8.

Khadra MH, Pickard RS, Charlton M, et al. A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice. J Urol. 2000; 163:524–7.

Jung H, Gleason JM, Loo RK, et al. Association of hematuria on microscopic urinalysis and risk of urinary tract cancer. J Urol. 2011; 185:1698-70. http://dx.doi.org/10.1016/j.juro.2010.12.093

Wollin T, Laroche B, Psooy K. Canadian guidelines for the management of asymptomatic microscopic hematuria in adults. Can Urol Assoc J. 2009; 3:77-80.

Anderson J, Fawcett D, Feehally J, et al. Joint Consensus Statement on the Initial Assessment of Haematuira. July 2008. BAUS/RA Guidelines.

Kassouf W, Aprikian A, Black P, et al. Recommendations for the improvement of bladder cancer quality of care in Canada: A consensus document reviewed and endorsed by Bladder Cancer Canada (BCC), Canadian Urologic Oncology Group (CUOG), and Canadian Urological Association (CUA), December 2015. Can Urol Assoc J. 2016; 10(1-2):E46-80. http://dx.doi.org/10.5489/cuaj.3583

Davis R, Jones JS, Barocas DA, et al. Diagnosis, evaluation and follow-up of asymptomatic microhematuria (AMH) in adults: AUA guideline 2012. Unabridged on-line version, available at www.auanet.org. Accessed Dec 30, 2017.

Biardeau X, Lam O, Van Ba, et al. Prospective evaluation of anxiety, pain and embarrassment associated with cystoscopy and urodynamic testing in clinical practice. Can Urol Assoc J. 2017; 11(3-4): 104-10. http://dx.doi.org/10.5489/cuaj.4127

Ellis G, Pridgeon S, Lamb BW, et al. Psychological distress in out-patients undergoing flexible cystoscopy for the investigations of bladder cancer. J of Clinical Urology. 2015; Vol 8(3) 196-201. doi:10.1177/2051415814551821

Raheem OA, Mirheydar HS, Lee HJ, et al. Does listening to music during office-based flexible cystoscopy decrease anxiety in patients; a prospective randomized trial. J of Endo. 2017. Vol 29(7) 791-796. doi:10.1089/end.2015.0029

American Board of Internal Medicine Foundation [press release] Choosing Wisely: five things physicians and patients should question. Washington, DC: American Board of Internal Medicine Foundation; 2012. Accessed July 1, 2018 from:

www.choosingwisely.org/choosing-wisely-five-things-physicians-and-patients-should-question-press-release-april-4-2012/.

Canadian Medical Association [website] Choosing Wisely Canada. Ottawa, ON: Canadian Medical Association; 2014. Accessed June 10, 2018 from:

www.cma.ca/En/Pages/choosing-wisely-canada.aspx.

Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap) – A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009 Apr;42(2):377-81

Lippmann QK, Slezak JM, Menefee SA, et al. Evaluation of microscopic hematuria and risk of urologic cancer in female patients. Am. J. Obstet. Gynecol. February 2017; 216:146.e1-7.

Published
2019-02-07
How to Cite
Assmus, M. A., Beyer, D. B., Hanks, J., Estey, M., Rourke, K. F., Schuler, T., & Wollin, T. A. (2019). Quality and cost assessment of Canadian Urological Association microscopic hematuria guidelines in clinical practice: Turning urine into gold. Canadian Urological Association Journal, 13(12), 406-11. https://doi.org/10.5489/cuaj.5809
Section
Original Research